Suchergebnisse - "Wilkins, John T"

PubPharm (6)

1

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk : A Report of the American College of Cardiology Solution Set Oversight Committee

enthalten in: Journal of the American College of Cardiology | 2022

von Writing Committee | Lloyd-Jones, D. | Morris, P. | +9

ErratumIn: J Am Coll Cardiol. 2023 Jan 3;81(1):104. - PMID 36599606

2

Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk

enthalten in: JAMA | 2021

von Wilkins, J. | Lloyd-Jones, D.

ErratumIn: JAMA. 2021 Oct 26;326(16):1637. - PMID 34554177

3

Does Lowering Low-Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle-Aged Adults? Analysis of the Observational MESA Study

enthalten in: Journal of the American Heart Association | 2021

von Liu, K. | Wilkins, J. | Colangelo, L. | +1

4

PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

enthalten in: The Cochrane database of systematic reviews | 2020

von Schmidt, A. | Carter, J. | Pearce, L. | +4

UpdateOf: Cochrane Database Syst Rev. 2017 Apr 28;4:CD011748. - PMID 28453187

5

PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

enthalten in: The Cochrane database of systematic reviews | 2017

von Schmidt, A. | Pearce, L. | Wilkins, J. | +3

CommentIn: Heart. 2018 Jul;104(13):1053-1055. - PMID 29444808

6

Prevention : HOPE-3 trial - targeting BP and LDL-C in at-risk patients

enthalten in: Nature reviews. Cardiology | 2016

von Wilkins, J. | Lloyd-Jones, D.

1
[1]